HilleVax Competitors and Similar CompaniesClear all

HilleVax's competitors and similar companies include Domain Therapeutics, Absci, Vigil Neuroscience and e-therapeutics.

	HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.	Domain Therapeutics Domain Therapeutics is a biopharmaceutical company.	Absci AbSci is a company that provides generative AI drug-creation solutions.	Vigil Neuroscience Vigil Neuroscience is a company that discovers therapeutics for neurodegenerative diseases.	e-therapeutics e-therapeutics is a computational drug discovery company.
Founding Date	Founding Date 2020	Founding Date 2001	Founding Date 2011	Founding Date 2020	Founding Date 2003
Type	Type Public	Type Private	Type Public	Type Public	Type Private
Tags	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma	Tags Technology artificial intelligence biotech drug development platform	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma
Locations	Locations Boston, US HQ	Locations Illkirch-Graffenstaden, FR HQ Montréal, CA	Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US	Locations Cambridge, US HQ	Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB
Employees	Employees 31	Employees 811% decrease	Employees 1561% increase	Employees 34	Employees 58
Valuation ($)	Valuation ($) 95.1 m	Valuation ($) N/A	Valuation ($) 487.2 m	Valuation ($) 151.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($147.3m) (FY, 2024)	Net income N/A	Net income ($115.2m) (FY, 2025)	Net income ($84.3m) (FY, 2024)	Net income (£14.9m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 41.5m	Total funding raised $ 217.5m	Total funding raised $ 140m	Total funding raised $ 66.8m